Search
Filter Results
Displaying 21–30 of 253 for “adeno-associated virus”
-
Apr 11, 2024
ViGeneron Launches Clinical Trial of Gene Therapy for RP Caused by CNGA1 Mutations
The gene therapy is administered using a less-invasive intravitreal injection.
-
Apr 8, 2024
Ocugen to Launch Phase 3 Clinical Trial of Modifier Gene Therapy for RP
The emerging treatment is designed to work independent of the patient’s mutated gene.
-
Sep 18, 2023
Ocugen Reports Updated Results for Clinical Trial of Modifier Gene Therapy
The company is also launching modifier gene therapy clinical trials for GA and Stargardt disease
-
Nov 10, 2022
Uni-Rare Study will improve clinical understanding of more IRDs and boost development of potential therapies.
-
Mar 7, 2022
Neurogene to Launch Gene Therapy Clinical Trial for Children with Batten Disease
The treatment will be delivered to the vitreous of the eye and ventricles of the brain
-
Dec 13, 2021
Ocugen to Launch Clinical Trial for Cross-Cutting RP Gene Therapy
The clinical trial is for RHO and NR2E3 mutations, but the retinal gene therapy has the potential to benefit people with a variety of other mutated genes
-
Oct 7, 2020
AGTC Joins the My Retina Tracker® Program as a New Scientific Collaborator
-
May 4, 2020
#GivingTuesdayNow Featured Researcher Dr. Shannon Boye
A Lifelong Science Nerd is Winning the Fight Against Blindness
-
Feb 27, 2020
Researchers Report Six-Month Results from Biogen-Sponsored XLRP Gene Therapy Clinical Trial
Vision improvements observed with medium and high doses
-
Nov 7, 2019
AGTC Announces Development of Stargardt Disease Gene Therapy
Dual-vector delivery system designed to deliver the large ABCA4 gene